Structure |
Chemical Name |
CAS |
MF |
 |
1,3-Benzodioxole-5-acetic acid methyl ester |
326-59-0 |
C10H10O4 |
 |
L-(+)-Ergothioneine |
497-30-3 |
C9H15N3O2S |
 |
Material intermediate |
162039-67-0 |
C18H14N4 |
 |
(3-BROMOACETYL)COUMARIN |
29310-88-1 |
C11H7BrO3 |
 |
Primary Prostaglandin Metabolite LC-MS Mixture |
|
|
 |
Sugammadex sodium Heptabromide intermediate |
|
|
 |
Rabacfosadine succinate |
1431856-99-3 |
C25H41N8O10P |
 |
Cefotiam (6R,7S) isomer reference |
|
|
 |
RebaMipide interMediate product |
169809-59-0 |
C19H16ClN2NaO4 |
![tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate](/CAS/GIF/866084-31-3.gif) |
tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
866084-31-3 |
C33H45N7O4 |
![(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one](/CAS/20150408/GIF/415927-29-6.gif) |
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one |
415927-29-6 |
C34H51F5O3S |
 |
5-Bromo-2-methylbenzoic acid |
79669-49-1 |
C8H7BrO2 |
 |
EthanediaMide iMpurity F hcl |
482375-18-8 |
C2H4N2O2 |
![N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/20150408/GIF/CB82682578.gif) |
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1702274-61-0 |
C20H25N5 |
![(3S)-10-Fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid](/CAS/20150408/GIF/117620-84-5.gif) |
(3S)-10-Fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid |
117620-84-5 |
C13H10FNO4 |
 |
2-Chloro-4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidine |
1269440-58-5 |
C10H10ClIN4 |
 |
Coumarin |
15938-72-4 |
C28H22O9 |
 |
4-TERT-BUTOXYCARBONYLAMINO-PIPERIDINE-1,4-DICARBOXYLIC ACID MONOBENZYL ESTER |
252720-32-4 |
C19H26N2O6 |
![(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate](/CAS/20180808/GIF/186488-43-7.gif) |
(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate |
186488-43-7 |
C8H12O4 |
 |
Bis(4-isopropylphenyl)iodonium chloride |
97671-66-4 |
C18H22ClI |
 |
(3S,4R,5R)-Oseltamivir |
|
|
![4-Benzo[b]thien-2-ylbenzenamine](/CAS/20200611/GIF/54492-95-4.gif) |
4-Benzo[b]thien-2-ylbenzenamine |
54492-95-4 |
C14H11NS |
![Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-(6-fluoro-3-pyridinyl)-6-hydroxy-](/CAS/20181212/GIF/2222654-09-1.gif) |
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-(6-fluoro-3-pyridinyl)-6-hydroxy- |
2222654-09-1 |
C13H7FN4O |
 |
1-chloro-8-phenyl-Dibenzofuran |
2379717-75-4 |
C18H11ClO |
![2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid](/) |
2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid |
|
|
 |
Isopropyl 2-((5-amino-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate |
1847465-25-1 |
C29H37N7O3 |
 |
7-amino-3-phenyl-2-benzopyrone |
4108-61-6 |
C15H11NO2 |
 |
methyl ibogamine-18-carboxylate |
467-77-6 |
C21H26N2O2 |
 |
4-Methylcumarin |
607-71-6 |
C10H8O2 |
 |
Dabigatran intermediate |
|
|
 |
1,1-Dimethylethyl 10,10-dimethyl-8-oxo-3,9-dioxa-2,7-diazaundecanoate |
1243021-74-0 |
C13H26N2O5 |
 |
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
 |
2'-DEOXYCYTIDINE MONOHYDRATE, 99+% |
652157-52-3 |
C9H15N3O5 |
 |
tert-butyl (3R,6S)-3-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino) -6-carbamoyl -5-methyl-3,6-dihydropyridine-1(2H)-carboxylate |
2209874-00-8 |
C23H43N3O6Si |
 |
(S)-3-(4-CHLOROPHENYL)-BETA-ALANINOL
|
886061-26-3 |
C9H12ClNO |
 |
Silicone intermediate |
|
|
![7-Chloro-1H-pyrrolo[3,2-b]pyridine](/CAS/GIF/357263-48-0.gif) |
7-Chloro-1H-pyrrolo[3,2-b]pyridine |
357263-48-0 |
C7H5ClN2 |
 |
BORTEZOMIB-PINANEDIOL |
205393-22-2 |
C29H39BN4O4 |
 |
4-AMINO-CHROMEN-2-ONE |
53348-92-8 |
C9H7NO2 |
![[402960-19-4],C9H18N2O2, 186.40](/CAS/20180808/GIF/850252-34-5.gif) |
[402960-19-4],C9H18N2O2, 186.40 |
850252-34-5 |
C9H19ClN2O2 |
 |
α-Ergocryptine |
511-09-1 |
C32H41N5O5 |
![a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate](/CAS/GIF/114869-97-5.gif) |
a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate |
114869-97-5 |
C40H47NO15 |
 |
N-blocked-5'-O-DMT-2'-O-Me CED cytosine phosphoramidite |
110764-78-8 |
C47H54N5O9P |
 |
S-(+)-Methoprene |
65733-16-6 |
C19H34O3 |
 |
PROSTAGLANDIN A2 |
13345-50-1 |
C20H30O4 |
 |
Engelide intermediate |
|
|
 |
Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate |
154330-68-4 |
C16H15F2NO4S |
![(5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride](/CAS/20180703/GIF/1373116-04-1.gif) |
(5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride |
1373116-04-1 |
C25H37ClF2N2OSi |
 |
Cefiderocol |
1225208-94-5 |
C30H34ClN7O10S2 |
 |
2,3-Dimethylbenzyl alcohol |
13651-14-4 |
C9H12O |
 |
(1R)-(+)-TRANS-PINANE |
4863-59-6 |
C10H18 |
 |
ABT-494 intermediate |
1428243-24-6 |
C15H19NO4 |
 |
5-Methyl-4-isoxazolecarboxylic acid |
42831-50-5 |
C5H5NO3 |
 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN E2 |
363-23-5 |
C20H32O5 |
 |
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
 |
Inosine API manufacturers |
|
|
 |
3’-deoxyinosine |
|
|
 |
Acetoxy Ceftazidime Intermediate |
|
|
 |
Flomoxef Intermediate FXMT |
|
|
 |
4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN |
46895-13-0 |
C12H10O6 |
![8-bromo-1,4-dioxaspiro[4.5]decane](/CAS/20150408/GIF/68278-51-3.gif) |
8-bromo-1,4-dioxaspiro[4.5]decane |
68278-51-3 |
C8H13BrO2 |
 |
Retigabine Dihydrochloride |
150812-13-8 |
C16H20Cl2FN3O2 |
 |
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
853029-57-9 |
C20H17BrN6O2 |
 |
DMT-2′O-MOE-rMeC(bz) Phosphoramidite |
163759-94-2 |
C50H60N5O10P |
![4-[[6-[(1-Oxo-2-propen-1-yl)oxy]hexyl]oxy]benzoic acid 1,1'-(1,4-phenylene) ester](/CAS/GIF/123864-17-5.gif) |
4-[[6-[(1-Oxo-2-propen-1-yl)oxy]hexyl]oxy]benzoic acid 1,1'-(1,4-phenylene) ester |
123864-17-5 |
C38H42O10 |
 |
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine |
314771-76-1 |
C18H16ClFN4O2 |
 |
RTI 4229-111 |
150653-91-1 |
C16H20Cl3NO2 |
![3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine](/CAS/20150408/GIF/330786-24-8.gif) |
3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine |
330786-24-8 |
C17H13N5O |
 |
Cabazitaxel N-3 |
859498-31-0 |
C57H61Cl6NO19 |
 |
Micafungin FR-179642 impurity (acid) |
168110-44-9 |
C35H52N8O20S |
 |
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate |
900186-73-4 |
C26H26N2O5 |
 |
Coumarin |
10172-75-5 |
C26H18O7 |
 |
PROSTAGLANDIN H2 |
42935-17-1 |
C20H32O5 |
 |
2,4-dihydroxy-6-propyl-benzoic acid methyl ester |
55382-52-0 |
C11H14O4 |
 |
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate |
1050477-44-5 |
C24H24N4O4 |
 |
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
 |
1-Vinylimidazole |
1072-63-5 |
C5H6N2 |
 |
2'-CHLORO-2'-DEOXYURIDINE |
4753-04-2 |
C9H11ClN2O5 |
 |
FMOC-21-AMINO-4,7,10,13,16,19-HEXAOXAHENEICOSANOIC ACID |
882847-34-9 |
C30H41NO10 |
 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA |
27376-76-7 |
C20H34O5 |
 |
Posaconazole Impurity 16 |
213381-02-3 |
C37H42F2N8O4 |
 |
4,7-DIMETHYLCOUMARIN |
14002-90-5 |
C11H10O2 |
 |
5-Fluoroindole |
399-52-0 |
C8H6FN |
 |
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
 |
5-BRDU 5-bromo-2'-deoxyuridine |
|
|
 |
tetramethyl 3,3',3'',3'''-(porphyrin-5,10,15,20-tetrayl)tetrabenzoate |
75286-83-8 |
C52H38N4O8 |
 |
7-Chloro-1,2,3,4-tetrahydrobenzo(b)azepin-5-one |
160129-45-3 |
C10H10ClNO |
 |
4-methyl-7-nitro- 2H-chromen-2-one |
179897-88-2 |
C10H7NO4 |
 |
Cefradine double nucleus |
|
|
 |
Fulvestrant intermediate |
1610351-44-4 |
C30H46O6S |
 |
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole |
97963-62-7 |
C8H6F2N2OS |
 |
ADENYLYL(3'>5')CYTIDINE FREE ACID |
2382-66-3 |
C19H25N8O11P |
 |
CEFMETAZOLE MMT ISOMER |
|
|
 |
Cyclobutanecarboxylic acid, 3-(methylamino)-, 1-methylethyl ester, cis- |
2136718-64-2 |
C9H17NO2 |
 |
Vanadyl Riboside Complex (RVC/VRC) |
|
|
 |
Cefminox for system suitability |
|
|
 |
Flomoxef Intermediate NaMT |
|
|
 |
3,4-(Methylenedioxy)aniline |
14268-66-7 |
C7H7NO2 |
 |
Methenolone enanthate |
303-42-4 |
C27H42O3 |
 |
8-OXO-DG |
|
|